Mankind Pharma share price

NSE: MANKIND · Biotechnology & Drugs

₹2,475 -0.25%

Data as of 2026-11-03 (NSE close)

1-year price chart

2025-12-122026-02-122026-04-212026-06-222026-08-202026-11-091,7502,0002,2502,5002,750

Key ratios

Market cap

₹1.04L Cr

P/E

46.09x

P/B

6.25x

ROE

13.7%

ROCE

n/a

Debt / Equity

0.31

Dividend yield

0.00%

52W high / low

₹2,642 / ₹1,909.7

Latest Mankind Pharma news

Please find attached outcome of Board Meeting where Board has noted the merger of MCPPL & · Strota 2026-10-29

Mankind Pharma Q2 profit rises 38% to Rs 716 crore · The Economic Times 2026-10-26

Mankind Pharma Announces Q1 FY27 Profit and Revenue Results · Business Standard 2026-08-10

Mankind Pharma Q1 Net Profit Jumps 29.6% to ₹5.68 Billion on Robust Revenue Growth · Equitymaster 2026-08-03

Mankind Pharma to Acquire Bharat Serums and Vaccines for ₹13,630 Crore · CNBC TV18 2026-07-30

Biotechnology & Drugs peers

AI analysis

Sign up free to see the full analysis

Quantsgrow scorecard

Sign up free to see the full analysis

Disclaimer: Quantsgrow is a technology platform providing research tools and analytics. We do not provide investment advice or stock recommendations. Investments in securities markets are subject to market risks; read all related documents carefully before investing. Data is for research and educational purposes only. Where applicable, services are provided in association with SEBI registered intermediaries.